Data |
Ora |
Fonte |
Titolo |
10/12/2024 | 22:34 | EDGAR2 | Form 8-K - Current report |
10/12/2024 | 22:30 | GLOBE | ACELYRIN, INC. Announces Topline Results From Phase 2b/3.. |
13/11/2024 | 23:26 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
13/11/2024 | 22:03 | EDGAR2 | Form 8-K - Current report |
13/11/2024 | 22:01 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/11/2024 | 22:00 | GLOBE | ACELYRIN, INC. Reports Third Quarter 2024 Financial Results.. |
08/11/2024 | 20:17 | EDGAR2 | Form SC 13G - Statement of Beneficial Ownership by Certain.. |
06/11/2024 | 22:00 | GLOBE | ACELYRIN, INC. to Report Third Quarter 2024 Financial.. |
04/11/2024 | 22:11 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
16/10/2024 | 13:00 | GLOBE | ACELYRIN, INC. Forms Scientific and Patient Advisory Board.. |
19/9/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Positive Results from Global Phase.. |
10/9/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Positive Proof-of-Concept Data From.. |
22/8/2024 | 13:00 | GLOBE | ACELYRIN, INC. to Participate in Upcoming Investor.. |
13/8/2024 | 22:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/8/2024 | 22:14 | EDGAR2 | Form 8-K - Current report |
13/8/2024 | 22:00 | GLOBE | ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep.. |
06/8/2024 | 22:30 | GLOBE | ACELYRIN, INC. to Report Second Quarter 2024 Financial.. |
11/6/2024 | 23:05 | EDGAR2 | Form 8-K - Current report |
05/6/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Positive 16-week Data From its.. |
29/5/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Lonigutamab Phase 1/2.. |
28/5/2024 | 23:20 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
25/5/2024 | 01:12 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
25/5/2024 | 01:10 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
25/5/2024 | 01:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
18/5/2024 | 01:12 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
18/5/2024 | 01:09 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
18/5/2024 | 01:05 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
14/5/2024 | 22:22 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/5/2024 | 14:14 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
09/5/2024 | 14:13 | EDGAR2 | Form 8-K - Current report |
09/5/2024 | 14:01 | GLOBE | ACELYRIN, INC. Provides Business Update and Highlights Key.. |
09/5/2024 | 14:00 | GLOBE | ACELYRIN, INC. Announces Leadership Transition |
29/4/2024 | 22:05 | GLOBE | ACELYRIN, INC. to Report First Quarter 2024 Financial.. |
28/3/2024 | 21:05 | GLOBE | ACELYRIN, INC. Reports Full Year 2023 Financial Results and.. |
27/3/2024 | 21:01 | GLOBE | Avalo Acquires Anti-IL-1β mAb and Announces Private.. |
20/3/2024 | 12:00 | GLOBE | ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept.. |
11/3/2024 | 13:05 | EDGAR2 | Form 8-K - Current report |
11/3/2024 | 13:02 | GLOBE | ACELYRIN, INC. Announces Positive Top-line Results from Its.. |
11/3/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Long-term 32-Week Data from the.. |
15/2/2024 | 22:05 | GLOBE | ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President,.. |
12/1/2024 | 11:45 | PRNUS | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders.. |
12/1/2024 | 00:38 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/1/2024 | 00:31 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
05/1/2024 | 11:45 | PRNUS | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders.. |